Colony »

Fate Therapeutics shares owned by Colony

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Colony from 13F filings

Historical chart of Colony investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Colony

Quarter filed Position value Share count Share price at filing
2024-09-30 $83k 24k 3.50
2024-06-30 $78k 24k 3.26
2024-03-31 $174k 24k 7.36

More positions owned by Colony

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Ea Series Trust Ea Bridgeway Omn (BSVO)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Internatnal Val (DFIV)
Amazon (AMZN)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Colony

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
BlackRock
Deep Track Capital
State Street Corporation
Boxer Capital
Bellevue Group
Citadel Advisors
Deerfield Management Company
Johnson & Johnson
D. E. Shaw & Co
Morgan Stanley
Woodline Partners
Baker Bros. Advisors

View all funds holding Fate Therapeutics